Inflammatory bowel disease is a life-long relapsing and remitting inflammatory disorder primarily affecting the gastrointestinal tract.
Invasive diagnostic investigations, specifically colonoscopy and histopathological evaluation, are the current standard for diagnosis.
This invention provides a method of diagnosing or assessing inflammatory bowel disease including Crohn’s disease and Ulcerative Colitis using a set of six protein/peptide markers by comparing the level of one or more markers relative to a reference value for the one or more markers.
The technology is also capable of distinguishing between Ulcerative Colitis and Crohn’s disease and the severity of the condition.
The development of a point of care diagnostic test would provide:
- Non-invasive testing
- Rapid test and results
- Accurate diagnosis
- Significant reduction in medical costs
- Faster intervention - better treatment options
- Better disease management
UNSW is seeking a commercial partner to licence and/or to work collaboratively with the inventor Dr Valerie Wasinger in the development of this diagnostic test.